Don't Switch From Vancomycin for MRSA Bacteremia Just for an MIC of 2 mg/L

July 2019

We're getting questions about the optimal treatment for methicillin-resistant Staph aureus (MRSA) bacteremia in adults.

Consider these strategies when treating your patients.

Continue to use vancomycin first. Daptomycin is also first-line, but there's no good evidence it works better...and it costs more.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

MRSA Don't Switch From Vancomycin for MRSA Bacteremia Just for an MIC of 2 mg/L
Allergic Reactions Sort Through Options When Treating Patients Reporting a Penicillin Allergy
Liver Disease Maximize Safety When Using Anticoagulants in Patients With Cirrhosis
Asthma Don't Assume Using Combo Steroid Asthma Inhalers AS NEEDED Is Wrong
Infectious Diseases Don't Screen for UTIs in Most Patients Without Symptoms
Public Health Recognize Human Trafficking Victims Hidden in Plain Sight
HIV & AIDS Avoid Errors With the New HIV Med, Dovato
Drug Costs Be Prepared for Questions About Medication Prices in TV Ads
Devices Put Sensors for Inhalers in Perspective